SLC2A3 and neoplasm: Moreover, the expression levels of SLC2A3 have been identified as a significant prognostic marker for disease-free, relapse-free, and overall survival, with higher expression levels correlating with poorer disease-free survival and more aggressive tumor characteristics [7].